UBS Asset Management
9
248M
5
1
0.44
2
- Areas of investment
Summary
The main office of represented Corporate Investor is situated in the London. The company was established in Europe in United Kingdom.
The higher amount of exits for fund were in 2019. The common things for fund are deals in the range of 50 - 100 millions dollars. The fund is generally included in less than 2 deals every year. Opposing the other organizations, this UBS Asset Management works on 11 percentage points more the average amount of lead investments. The top activity for fund was in 2016.
The usual cause for the fund is to invest in rounds with 6-7 partakers. Despite the UBS Asset Management, startups are often financed by MPM Capital, Taiho Ventures, New Leaf Venture Partners. The meaningful sponsors for the fund in investment in the same round are MPM Capital, Taiho Ventures, New Leaf Venture Partners. In the next rounds fund is usually obtained by MPM Capital, Taiho Ventures, New Leaf Venture Partners.
Among the most popular portfolio startups of the fund, we may highlight TCR2, Harpoon Therapeutics. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. Among the most popular fund investment industries, there are Life Science, Therapeutics.
Investments analytics
Analytics
- Total investments
- 9
- Lead investments
- 1
- Exits
- 2
- Follow on index
- 0.44
- Investments by industry
- Biotechnology (5)
- Health Care (5)
- Therapeutics (5)
- Medical (2)
- Life Science (2) Show 11 more
- Investments by region
-
- France (2)
- United States (7)
- Peak activity year
- 2020
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 12
- Avg. valuation at time of investment
- 100M
- Group Appearance index
- 0.78
- Strategy success index
- 0.40
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Harpoon Therapeutics | 25 May 2017 | Biotechnology, Health Care, Therapeutics | Early Stage Venture | 45M | United States, California, South San Francisco |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.